Post-earnings recap
Reported
Mon, Aug 2, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Charles River Laboratories fell short on EPS expectations, which contributed to a 3.89% decline in stock price. Investors may be concerned about the lack of revenue data and forward guidance, reflecting uncertainty about the company's future performance. The market reaction suggests cautious sentiment among investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.49 | N/A | -1.21% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding future performance without offering specific guidance. They highlighted ongoing market challenges.
Management did not provide specific guidance for the upcoming quarters.
The company acknowledged challenges in the current market environment.